SAFETY AND TOLERABILITY OF PROBIOTIC AND SYNBIOTIC SUPPLEMENTATION DURING CHEMOTHERAPY
DOI:
https://doi.org/10.47413/14xthe77Abstract
Chemotherapy, while essential in cancer treatment, often causes gastrointestinal (GI) toxicity due to its damaging effects on the gut epithelium and disruption of the microbiota. Probiotic and synbiotic supplementation has emerged as a promising adjunct to alleviate these side effects by modulating gut microbiota, enhancing mucosal integrity, and reducing inflammation. This review synthesizes current evidence on the safety and tolerability of probiotics and synbiotics during chemotherapy. Clinical trials have demonstrated reductions in chemotherapy-induced diarrhea, mucositis, and abdominal discomfort, particularly with strains like Lactobacillus and Bifidobacterium. Synbiotics offer additional benefits by enhancing probiotic survival and activity through prebiotic synergy. However, safety concerns remain, especially in immunocompromised patients, with rare reports of probiotic-associated infections. Most adverse effects are mild and transient, such as bloating or flatulence. Guidelines recommend cautious use, emphasizing strain specificity, product quality, and individualized risk assessment. Despite encouraging outcomes, challenges such as study heterogeneity, lack of standardized protocols, and product variability persist. Future directions include large-scale trials, personalized supplementation based on microbiome profiling, mechanistic studies, and development of regulatory standards. With appropriate clinical oversight, probiotics and synbiotics hold potential as safe, effective, and patient-friendly interventions to support cancer therapy.
References
1. Chen, J., Zhao, J., Wu, H., Wang, T., & Gao, C. (2024). RETRACTED: Efficacy and safety of oral probiotic supplementation in mitigating postoperative surgical site infections in patients undergoing colorectal cancer surgery: A systematic review and meta‐analysis. International Wound Journal, 21(4). https://doi.org/10.1111/iwj.14603
2. Dahlgren, D., Sjöblom, M., Hellström, P. M., & Lennernäs, H. (2021). Chemotherapeutics-Induced Intestinal Mucositis: Pathophysiology and Potential Treatment Strategies. Frontiers in Pharmacology, 12, 681417. https://doi.org/10.3389/fphar.2021.681417
3. Davani-Davari, D., Negahdaripour, M., Karimzadeh, I., Seifan, M., Mohkam, M., Masoumi, S., Berenjian, A., & Ghasemi, Y. (2019). Prebiotics: Definition, Types, Sources, Mechanisms, and Clinical Applications. Foods, 8(3), 92. https://doi.org/10.3390/foods8030092
4. Gibson, G. R., Hutkins, R., Sanders, M. E., Prescott, S. L., Reimer, R. A., Salminen, S. J., Scott, K., Stanton, C., Swanson, K. S., Cani, P. D., Verbeke, K., & Reid, G. (2017). Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nature Reviews Gastroenterology & Hepatology, 14(8), 491–502. https://doi.org/10.1038/nrgastro.2017.75
5. Han, H., Zhang, Y., Tang, H., Zhou, T., & Khan, A. (2024). A Review of the Use of Native and Engineered Probiotics for Colorectal Cancer Therapy. International Journal of Molecular Sciences, 25(7). https://doi.org/10.3390/ijms25073896
6. Hassan, H., Rompola, M., Glaser, A. W., Kinsey, S. E., & Phillips, R. S. (2018). Systematic review and meta-analysis investigating the efficacy and safety of probiotics in people with cancer. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer, 26(8), 2503–2509. https://doi.org/10.1007/s00520-018-4216-z
7. He, Y., Fu, L., Li, Y., Wang, W., Gong, M., Zhang, J., Dong, X., Huang, J., Wang, Q., Mackay, C. R., Fu, Y.-X., Chen, Y., & Guo, X. (2021). Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8+ T cell immunity. Cell Metabolism, 33(5), 988-1000.e7. https://doi.org/10.1016/j.cmet.2021.03.002
8. Hill, C., Guarner, F., Reid, G., Gibson, G. R., Merenstein, D. J., Pot, B., Morelli, L., Canani, R. B., Flint, H. J., Salminen, S., Calder, P. C., & Sanders, M. E. (2014). The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology & Hepatology, 11(8), 506–514. https://doi.org/10.1038/nrgastro.2014.66
9. Kan, H. X., Cao, Y., Ma, Y., Zhang, Y. L., Wang, J., Li, J., & Li, J. N. (2024). Efficacy and safety of probiotics, prebiotics, and synbiotics for the prevention of colorectal cancer and precancerous lesion in high‐risk populations: A systematic review and meta‐analysis of randomized controlled trials. Journal of Digestive Diseases, 25(1), 14–26. https://doi.org/10.1111/1751-2980.13247
10. López-Gómez, L., Alcorta, A., & Abalo, R. (2023). Probiotics and Probiotic-like Agents against Chemotherapy-Induced Intestinal Mucositis: A Narrative Review. Journal of Personalized Medicine, 13(10). https://doi.org/10.3390/jpm13101487
11. Markowiak-Kopeć, P., & Śliżewska, K. (2020). The Effect of Probiotics on the Production of Short-Chain Fatty Acids by Human Intestinal Microbiome. Nutrients, 12(4), 1107. https://doi.org/10.3390/nu12041107
12. Markowiak, P., & Śliżewska, K. (2017). Effects of Probiotics, Prebiotics, and Synbiotics on Human Health. Nutrients, 9(9), 1021. https://doi.org/10.3390/nu9091021
13. McCallum, B., Otiti, I., Achieng, F., Allen, S., & Worral, E. (2024). An early-stage cost and implementation feasibility study of the administration of pro/synbiotics to infants 0-5 months in rural Kenya. https://doi.org/10.1101/2024.12.17.24319142
14. Mizutani, Y., Kawamoto, S., Takahashi, M., Doi, H., Wakida, K., Tabuchi, S., Tanda, M., Soga, A., Chijiki, R., Takakura, H., Kawaguchi, K., Higashime, A., Watanabe, M., Ichikawa, H., Matsumoto, S., Sakai, R., Goto, H., Kurata, K., Kakiuchi, S., … Minami, H. (2023). Efficacy and Safety of Synbiotics in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Randomized, Double-blinded, Placebo-controlled Pilot Study. Internal Medicine, 62(20), 1314–1322. https://doi.org/10.2169/internalmedicine.1314-22
15. Motoori, M., Yano, M., Miyata, H., Sugimura, K., Saito, T., Omori, T., Fujiwara, Y., Miyoshi, N., Akita, H., Gotoh, K., Takahashi, H., Kobayashi, S., Noura, S., Ohue, M., Asahara, T., Nomoto, K., Ishikawa, O., & Sakon, M. (2017). Randomized study of the effect of synbiotics during neoadjuvant chemotherapy on adverse events in esophageal cancer patients. Clinical Nutrition, 36(1), 93–99. https://doi.org/10.1016/j.clnu.2015.11.008
16. Osterlund, P., Ruotsalainen, T., Korpela, R., Saxelin, M., Ollus, A., Valta, P., Kouri, M., Elomaa, I., & Joensuu, H. (2007). Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study. British Journal of Cancer, 97(8), 1028–1034. https://doi.org/10.1038/sj.bjc.6603990
17. Pal, P., & Shastry, R. P. (2023). Exploring the complex role of gut microbiome in the development of precision medicine strategies for targeting microbial imbalance-induced colon cancer. Folia Microbiologica, 68(5), 691–701. https://doi.org/10.1007/s12223-023-01085-5
18. Plaza-Diaz, J., Ruiz-Ojeda, F. J., Gil-Campos, M., & Gil, A. (2019). Mechanisms of Action of Probiotics. Advances in Nutrition, 10, S49–S66. https://doi.org/10.1093/advances/nmy063
19. Rafter, J., Bennett, M., Caderni, G., Clune, Y., Hughes, R., Karlsson, P. C., Klinder, A., O’Riordan, M., O’Sullivan, G. C., Pool-Zobel, B., Rechkemmer, G., Roller, M., Rowland, I., Salvadori, M., Thijs, H., Van Loo, J., Watzl, B., & Collins, J. K. (2007). Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. The American Journal of Clinical Nutrition, 85(2), 488–496. https://doi.org/10.1093/ajcn/85.2.488
20. Raji Lahiji, M., Zarrati, M., Najafi, S., Yazdani, B., Cheshmazar, E., Razmpoosh, E., Janani, L., Raji Lahiji, M., & Shidfar, F. (2021). Effects of synbiotic supplementation on serum adiponectin and inflammation status of overweight and obese breast cancer survivors: a randomized, triple-blind, placebo-controlled trial. Supportive Care in Cancer, 29(7), 4147–4157. https://doi.org/10.1007/s00520-020-05926-8
21. Redman, M. G., Ward, E. J., & Phillips, R. S. (2014). The efficacy and safety of probiotics in people with cancer: a systematic review. Annals of Oncology, 25(10), 1919–1929. https://doi.org/10.1093/annonc/mdu106
22. Sanders, M. E., Merenstein, D. J., Ouwehand, A. C., Reid, G., Salminen, S., Cabana, M. D., Paraskevakos, G., & Leyer, G. (2016). Probiotic use in at-risk populations. Journal of the American Pharmacists Association, 56(6), 680–686. https://doi.org/10.1016/j.japh.2016.07.001
23. Šimiaková, M., & Bielik, V. (2024). The pros and cons of probiotic use in pediatric oncology patients following treatment for acute lymphoblastic leukemia. Frontiers in Pediatrics, 12. https://doi.org/10.3389/fped.2024.1427185
24. Sonis, S. T. (2009). Mucositis: The impact, biology and therapeutic opportunities of oral mucositis. Oral Oncology, 45(12), 1015–1020. https://doi.org/10.1016/j.oraloncology.2009.08.006
25. Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249. https://doi.org/10.3322/caac.21660
26. Swanson, K. S., Gibson, G. R., Hutkins, R., Reimer, R. A., Reid, G., Verbeke, K., Scott, K. P., Holscher, H. D., Azad, M. B., Delzenne, N. M., & Sanders, M. E. (2020). The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics. Nature Reviews Gastroenterology & Hepatology, 17(11), 687–701. https://doi.org/10.1038/s41575-020-0344-2
27. Thursby, E., & Juge, N. (2017). Introduction to the human gut microbiota. Biochemical Journal, 474(11), 1823–1836. https://doi.org/10.1042/BCJ20160510
28. Wieërs, G., Belkhir, L., Enaud, R., Leclercq, S., Philippart de Foy, J.-M., Dequenne, I., de Timary, P., & Cani, P. D. (2020). How Probiotics Affect the Microbiota. Frontiers in Cellular and Infection Microbiology, 9. https://doi.org/10.3389/fcimb.2019.00454
29. Yang, R., Liu, W., Cai, S., Feng, X., Chen, Y., Cheng, X., Ma, J., Ma, W., Tian, Z., & Yang, W. (2025). Evaluation of the efficacy of probiotics in the chemoradiotherapy of colorectal cancer: a meta-analysis of Randomized Controlled Trials. BMC Gastroenterology, 25(1), 312. https://doi.org/10.1186/s12876-025-03914-y
30. Yao, B., Wei, W., & Zhang, H. (2024). Efficacy of probiotics or synbiotics supplementation on chemotherapy-induced complications and gut microbiota dysbiosis in gastrointestinal cancer: a systematic review and meta-analysis. European Journal of Clinical Nutrition. https://doi.org/10.1038/s41430-024-01542-5
31. Zwielehner, J., Lassl, C., Hippe, B., Pointner, A., Switzeny, O. J., Remely, M., Kitzweger, E., Ruckser, R., & Haslberger, A. G. (2011). Changes in Human Fecal Microbiota Due to Chemotherapy Analyzed by TaqMan-PCR, 454 Sequencing and PCR-DGGE Fingerprinting. PLoS ONE, 6(12), e28654. https://doi.org/10.1371/journal.pone.0028654
Downloads
Published
Issue
Section
License
Copyright (c) 2025 VIDYA - A JOURNAL OF GUJARAT UNIVERSITY
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
How to Cite
